Vivos Therapeutics Inc.

Vivos Therapeutics Inc [NASDAQ: VVOS] loss -9.08% or -0.27 points to close at $2.76 with a heavy trading volume of 5180542 shares. The company report on April 9, 2024 at 2:45 PM that Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices.

Vivos Therapeutics Inc [NASDAQ: VVOS] traded at a high on Thursday, posting a 3.87 gain after which it closed the day’ session at $4.83. The company report on March 28, 2024 at 4:05 PM that Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial